Cargando…
T-cell based sieve analysis ties HLA A*02 to vaccine efficacy and IgA-C1 immune correlate in RV144 Thai trial
Autores principales: | Hertz, T, Gartland, A, Janes, H, Li, S, Fong, Y, Tomaras, GD, Morris, D, Geraghty, D, Kijak, GH, Edlefsen, PT, Rolland, M, Larsen, BB, Tovanabutra, S, Sanders-Buell, E, DeCamp, AC, Magaret, CA, Ahmed, H, Nariya, S, Wong, K, Zhao, H, Deng, W, Maust, BS, Bose, M, Howell, S, Lazzaro, M, Bates, A, Lei, E, Bradfield, A, Ibitamuno, G, Assawadarachai, V, O'Connel, RJ, deSouza, MS, Nitayaphan, S, Rerks-Ngarm, S, Robb, ML, McElrath, MJ, Haynes, BF, Michael, NL, Gilbert, PB, Mullins, JI, Kim, JH |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441303/ http://dx.doi.org/10.1186/1742-4690-9-S2-O61 |
Ejemplares similares
-
CD8 and CD4 Epitope Predictions in RV144: No Strong Evidence of a T-Cell Driven Sieve Effect in HIV-1 Breakthrough Sequences from Trial Participants
por: Dommaraju, Kalpana, et al.
Publicado: (2014) -
SieveSifter: a web-based tool for visualizing the sieve analyses of HIV-1 vaccine efficacy trials
por: Fiore-Gartland, Andrew, et al.
Publicado: (2017) -
Comprehensive Sieve Analysis of Breakthrough HIV-1 Sequences in the RV144 Vaccine Efficacy Trial
por: Edlefsen, Paul T., et al.
Publicado: (2015) -
V1/V2-directed antibodies elicited in RV144 vaccinees bind to a structurally polymorphic site
por: McLellan, JS, et al.
Publicado: (2012) -
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env-V2
por: Rolland, Morgane, et al.
Publicado: (2012)